IV Saline Solution in Short Supply, Flu May Be to Blame — Physician’s First Watch
IV Saline Solution in Short Supply, Flu May Be to Blame
By the Editors
The FDA is reporting a shortage of intravenous solutions, including saline used for volume repletion. The agency says there may be increased demand because of influenza-related hospitalizations. Previously, the agency reported a shortage of the oral suspension of the antiviral oseltamivir (Tamiflu).
In the CDC's most recent flu update, 40 states reported widespread influenza activity, up from 35 the prior week. About 60% of influenza-related hospitalizations were adults under age 65, a pattern consistent with the 2009 H1N1 flu pandemic. This is the first season that the H1N1 strain has been in wide circulation since 2009.